Nature's second progress report on the pandemic looks at the key factors to making vaccines safe, effective and welcomed by the public.#Nature's second progress report on the pandemic looks at the key factors to making vaccines safe, effective and welcomed by the public.#A health worker working at an intensive care unitdoi...
California Consumer Privacy Statement Use of cookies/Do not sell my data Return & Refund Policy Scientific American is part of Springer Nature, which owns or has commercial relations with thousands of scientific publications (many of them can be found at www.springernature.com/us). Scientific Amer...
On October 2, the total number of COVID-19 infections in the U.S. surpassed 7.32 million. Michael Ryan, executive director of the World Health Organization's Health Emergencies Programme, said there was no reason why the United States of America could not control this disease, but it ...
Public interest in COVID vaccines has waned, with only one in five adults getting vaccinated since last September, compared with about 80% who got the first dose. New Yorkers have been slightly above the national vaccination rate, while in Georgia only about 17% got the latest ...
So far, the country has kept its COVID-19 death toll at 5,235 through those relentless efforts. Yes, the virus has been constantly mutating, from Alpha to Beta to Delta, and now Omicron, with the global death rate going down and down. But that has been a gradual process in the past...
1.---I'mafraid Novel COVID-19(新冠病毒)___(spread)for a long time.--- That's why we still have to wear face masks to protect ourselves.相关知识点: 试题来源: 解析 willspread解析:---我恐怕新冠病毒还要要流传很长时间。---这就是为什么我们仍然要戴上口罩来保护自己下半句说我们还需...
The IRS has issued more than 61 million tax refunds so far in 2025. Here’s the average payment. Kimberly LankfordApril 11, 2025 3 Odd Tax Deductions Taxpayers who think outside the box might be eligible for some unique deductions.
Myocarditis, an inflammation of the heart muscle, usually responds well to treatment, theCDC says, and research shows people are more likely to develop myocarditis from a COVID infection than from the vaccine. "I think all of that needs to be weighed. And so that's why I hesitate to make...
After disappointing results from clinical trials last year, vaccine companies are working to make the shots more effective. Here's where the science stands now.
With demand for COVID-19 vaccines outpacing the world’s supplies, a frustrated public and policymakers want to know: How can we get more? A lot more. Right away. The problem: “It’s not like adding more water to the soup,” said vaccine specialist Maria Elena Bottazzi of ...